Advances in hematopoietic cell transplantation (HCT) technology and supportive care
techniques have led to improvements in long-term survival after HCT. Emerging indications …

The Childhood Cancer Survivor Study (CCSS) has assembled the largest cohort to date for
assessment of late mortality. Vital status and cause of death of all patients eligible for …

Purpose Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition
characterized by somatic mutations in the blood of otherwise healthy adults. We …

The prevalence of autologous and allogeneic hematopoietic cell transplantation (HCT)
survivors continues to increase. Among patients whose disease remains in remission for the …

Purpose Hematopoietic cell transplantation can cure hematologic malignancies and other
diseases, but this treatment can also cause late complications. Previous studies have …

Hematopoietic cell transplantation is a curative treatment for a variety of hematologic
diseases. Advances in transplantation technology have reduced early transplant-related …

Advances in hematopoietic cell transplantation (HCT) have led to an increasing number of
transplant survivors. To adequately support their healthcare needs, there is a need to know …

Hematopoietic stem cells (HSCs) are regarded as one of essential cell sources for treating
regenerative diseases. Among many stem cells, the feasibility of using adult-derived …

Long-term survival is now an expected outcome after hematopoietic cell transplantation
(HCT). However, the burden of morbidity long-term after HCT remains unknown. We …

Hematopoietic cell transplantation (HCT) recipients may be at an increased risk of
developing hypertension, diabetes, and dyslipidemia (referred to as cardiovascular risk …